Introduction
Medin is an amyloidogenic peptide that accumulates with aging in various arterial beds, being found in all 18 patients studied that were 57 years or older 1 and reported to be present in 97% of a cohort of Caucasian subjects above 50 years of age. 2 Despite this ubiquity, little is known about the physiologic or pathologic effects of medin. Medin is a 50 amino acid peptide derived from milk fat globule protein epidermal growth factor 8 (MFG-E8). 1, 3, 4 It is amyloidogenic and forms vascular amyloid in the aorta and arteries of the upper part of the body, including intracranial vessels. 1 Prefibrillar medin was shown to induce aortic smooth muscle death in vitro while increasing the production of matrix--metalloproteinase-2, 3 suggesting a possible link between medin and aortic wall degeneration. We showed in a preliminary study that human endothelial cell cultures exposed acutely to medin demonstrated oxidative stress and reduced nitric oxide (ÁNO) bioavailability, although the underlying mechanism/s were not explored, 5 similar to effects observed with other amyloidogenic proteins (light chain proteins in AL amyloidosis 6 and b-amyloid 7 ) . The effects of medin on human microvascular endothelial function are not known. Our aim is to test the hypotheses that medin induces human arteriole endothelial dysfunction through oxidative/nitrative stress and reduced ÁNO bioavailability, and that these effects are mediated via actions on receptor for advanced glycation endproducts (RAGE).
Methods

Medin peptide
Medin was expressed using pOPINS-medin in Lemo 21 (DE3) cells 8 and purified as previously described. 5 Expression was induced at OD600 $1.0 with isopropyl-b-D-thiogalacto-pyranoside (1 mM) for 16 h at 20 C. Cells were harvested by centrifugation and pellets resuspended in 6 M guanidine hydrochloride (GdmCl), 20 mM sodium phosphate, 20 mM NaCl, pH 8.0 . Cells were homogenized and cell debris removed by centrifugation. The supernatant was loaded onto a nickelnitrilotriacetic acid (Ni 2þ -NTA) column, washed with 6 M GdmCl, pH 8
and pH 6, and eluted with 6 M GdmCl, pH 2. Fusion protein was buffer exchanged into 20 mM Tris-Cl, 0.5 M NaCl, pH 7.4 , and the His6-SUMO tag removed with SUMO protease I. The protease and the tag were removed using a Ni 2þ -NTA column and the flow through containing medin buffer exchanged into phosphate buffered saline (PBS) and flash-frozen. Medin was confirmed at >95% purity by sodium dodecyl sulfate polyacrylamide gel electrophoresis and characterized by matrixassisted laser desorption and ionization mass spectrometry. Levels of endotoxin were assessed to be <0.5 ng/ml using the Limulus Amebocyte Lysate assay (Pierce, Dallas, TX).
Sources of human tissue
2.2.1Aortic tissue
We assessed tissue concentration of medin from aortic tissue (10 ascending, 2 descending) from 12 human subjects (61.25 ± 3.98 years, range 39-81 years, four females, eight males). Tissue was obtained following informed consent from patients undergoing aortic surgery at Liverpool Heart and Chest Hospital through Liverpool Biobank, with approval granted by the Biobank Governance Board (Project number 15-06). The demographic information is provided in Table 1 .
2.2.2Adipose arterioles
Research volunteers scheduled to undergo elective clinically indicated abdominal surgery (inguinal or umbilical herniorrhaphy) and who were not known to have vascular disease or diabetes provided written, informed consent for subcutaneous adipose tissue donation (N = 35, 60.9 ± 2.3 years old, 1 female, 34 males by self-reported gender). The study was approved and under the supervision of the Phoenix Veterans Affairs Institutional Review Board (Migrino 001/004/1041).
Leptomeningeal arterioles
Leptomeningeal tissue were collected from cadavers following rapid autopsy (post-mortem interval 2.90 4 . Additional details on demographic information on the brain donors are in Supplementary material online , Table S1 . All of the methods and procedures used conform to the principles outlined in the Declaration of Helsinki.
Determination of tissue medin content
Human aortic tissue was homogenized in PBS at 10% w/v (100 mg of wet tissue in 1 ml of PBS) using a MiniLys (Bertini Instruments, France). We performed a 40-times dilution of the patient samples (10% homogenate, followed by a 4-times sample dilution) to get the samples within the range of the standards 0-0.4 lM and then calculated the values back up to reflect the dilution process. Homogenized aorta samples and control medin at 0.1, 0.2, and 0.4 mM were mixed 1:1 with Novex tricine SDS sample buffer and heated to 70 C for 5 min. Samples were then loaded onto a 10-20% Novex tricine protein gel and subjected to electrophoresis in Novex tricine SDS running buffer according to the manufactures instructions (all Novex products sourced from Thermo Fisher Scientific, UK). Proteins were transferred to nitrocellulose (Protran 2 mm, Amersham GE Healthcare UK Ltd) for 1 h at 100 V. Western blots were blocked in 5% v/v donkey serum (EMD Millipore, UK) in PBS at room temperature with gentle shaking for 1 h. The blots were probed with medin antibody (custom antibody from GenicBio Hong Kong) at 1:1000 in PBS overnight at 4 C. Blots were thoroughly washed with PBS þ 1% Tween 20 (PBST) and then incubated with a 1:10 000 dilution of the secondary antibody, horseradish peroxidase conjugated donkey anti-rabbit (GE Healthcare, UK) for 1 h at room temperature. The blots were washed again in PBST prior to chemiluminescent visualization using ELC (EMD Millipore, UK). The blots were analyzed using the gel analyzer tools in ImageJ (National Institutes of Health, Bethesda, MD). A standard curve was plotted using the control medin samples and this was used to calculate the amount of medin in each of the tissue samples. No protein control for loading correction was assessed in the aortic tissue Western blot but investigators were careful in using a consistent %weight/volume amount of tissue for loading.
Human arteriole vasoreactivity
The details of the methodology have been previously reported. 6, 7, 10, 11 Adipose arterioles (161 ± 10 mm lumen diameter) were isolated and following cannulation, were pressurized to 60 mmHg, the estimated physiologic pressure of similar sized arterioles in vivo. The vessels were preconstricted with increasing doses of endothelin-1 (10 14 Calbiochem, San Diego, CA). The maximum medin dose selected in this study (5 mM) is at par with physiologic/pathologic levels determined from our aortic tissue assays. Leptomeningeal arterioles underwent similar assessment of dilator response to acetylcholine at baseline, and after washout, post-treatment dilator responses were measured following 1 h exposure to 5 lM medin ± 100 lM FPS-ZM1 or 300 U/ml PEG-SOD.
2.5
Nitric oxide, peroxynitrite, and superoxide production and measurement of endothelial cell viability
The details of the methodology have previously been reported. 10 Frozen primary culture human umbilical vein endothelial cells (HUVECs, Lonza, Walkersville, MD) at passage 1 isolated from pooled donors by the corporate source were cultured and frozen down for future experiments as per the source's recommended protocols to form a working stock culture to draw from. Fresh cultures were seeded from these stocks and cells (passages 5-8) were allowed to grow to full confluence before treatment. Individual experimental treatments were in separate seeded cultures from the frozen stocks. HUVECs seeded into 10 cm 2 conical culture tubes each with a glass cover slip at the bottom were treated with vehicle control, medin 5 mM without or with PEG-SOD (300 U/ml), FPS-ZM1 (100 lM), or BH4 (100 lM) for 1 h and medin 5 mM without or with FPS-ZM1 (100 mM) for 20 h. ÁNO, superoxide, and peroxynitrite production were measured in endothelial cells exposed to treatment for 1 and 20 h while endothelial cell viability was measured following exposure to treatment for 20 h. ÁNO production was assessed by directly measuring ÁNO head gas production for cells treated for 20 h, and using 4,5-diaminofluorescein diacetate (DAF-2 DA) fluorescence for cells and arterioles treated for 1 h, a well-validated fluorescence method to indirectly measure ÁNO production. 15 
Endothelial dysfunction induced by medin
Adipose arterioles were exposed to 1 h treatment with vehicle control, medin 5 lM ± PEG-SOD (300 U/ml) or FPS-ZM1 (100 lM) and ÁNO was measured using DAF-2 DA staining while superoxide was measured using dihydroethidium staining similar to methods described above.
Endothelial cell proliferation and migration assay
To assess the effect of medin on cellular proliferation, HUVECs were plated in a 96-well plate at 8000 cells per well. After 24 h, cells were treated with medin 5 lM or vehicle and proliferation assay was performed on cells treated on day 0 and 2 days following treatment using Alamar Blue Assay (Thermo Fisher Scientific) modified from established protocol. 20 To perform the proliferation assay, media was removed from the well plate and the samples were washed three times with DPBS. The Alamar Blue solution was prepared in warmed culture media at concentration of 10% (v/v) and then added to each well followed by incubation for 4 h. Afterwards, fluorescence intensity was measured using a fluorescent plate reader (FLUOstar Omega, BMG LabTech, Ortenberg, Germany) at 544-590 nm wavelength.
A scratch-wound assay, modified from established protocol, 21 was utilized to analyze the effect of medin on endothelial cell migration. HUVECs were plated in 24-well plate and incubated until 90% confluent. Later, a pipette tip (20 ll) was used to perform a straight scratch in the well. The wells were next washed with DPBS and replaced with cell culture media as a control or media containing medin 5 lM. The 24 well-plate was placed into a microscope incubator and imaged for 8 h overnight. Next, each time point was analyzed by making 10 distance measurements between the scratch. Distance migrated were quantified in ImageJ 1.49 analysis software.
Pro-inflammatory signaling assays
The methodology for detecting gene and protein expression has been previously reported. 10 Quantitative polymerase chain reaction was used to measure gene expression. HUVECs (passages 4-8) in LONZA EGM-2 endothelial cell growth media were exposed to 20 h of vehicle control, medin 1 or 5 mM, without or with co-treatment of either FPS-ZM1 (100 mM) or RO106-9920 (1, 10, or 100 mM, Tocris Biosciences, Bristol, UK), a small molecule inhibitor of nuclear factor kappa-light-chainenhancer of activated B cells (NFjB)-dependent cytokine expression. 22 After cell lysis, RNA was extracted and converted to cDNA using Aurum Total RNA Mini Kit and iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). Primers for inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8) were purchased from Integrated DNA Technologies and polymerization signal was measured using SybrGreen on the Thermal Cycler CFX96 Real-Time System (BioRad Laboratories, Coralville, IA) with b-actin serving as reference gene for normalization. In separate experiments, HUVECs were treated for 20 h with vehicle control, medin 5 lM without or with either PEG-SOD (300 U/ml) or FeTMPyP (200 lM) and IL-6 and IL-8 gene expression were measured using similar methods. The conditioned cell media from above-treated HUVECs were collected for measurement of IL-6 and IL-8 protein and stored at -80 C until time of enzyme linked immunosorbent assay (ELISA). Conditioned media samples were thawed on ice and assayed either diluted 1:10 for IL-8 or assayed whole for IL-6 ELISA to keep values within range of the kit standards. Samples were assayed in duplicate as per instructions of the appropriate Human IL-6 or Human IL-8 Quantikine ELISA kit (R&D Systems, Minneapolis, MN).
Western blot assay
We measured total eNOS, phosphorylated eNOS (both serine 1177 and threonine 495) and computed phosphorylated eNOS:total eNOS ratio in HUVECs treated for 1 h with vehicle control and medin 5 lM± FPS-ZM1 (100 lM). In separate cells, we assessed whether medin's pro-inflammatory effect is through NFjB-mediated cytokine production, HUVECs were exposed for 5 h to vehicle control, medin 1 or 5 mM without or with FPS-ZM1 (100 mM). Cells were lysed in complete radioimmunoprecipitation assay-based lysis buffer with phosphatase inhibitor cocktail 2 and protease inhibitor (Sigma-Aldritch). 30 mg of protein (determined by Bradford assay) was loaded for electrophoresis in precast MiniProtean TGX 4-20% gel (Bio-Rad Laboratories). Proteins were transferred to polyvinylidene fluoride low fluorescence membrane for western blot at 100 V for 50 min. Antibodies against total eNOS (SigmaAldritch), phosphorylated eNOS (Cell Signaling, Danver, MA), phosphorylated NFjB (Cell Signaling) at 1:500, 1:1000, and 1:1000 dilution, respectively, were used and all membranes blocked a second time before developing via 680 RD or 800 CW infrared fluorescent conjugated goat secondary antibody (Li-COR Biosciences, Lincoln, NE) 1 to 15 000 dilution. Fluorescent bands in the infrared range were detected using Li-COR Odyssey CLx imaging system. Signal was measured using Image Studio 4.0 (Li-COR) normalized to b-actin and results are expressed as values relative to control.
Data and statistical analyses
Data are expressed as mean ± standard error of means with significant P-value (two-sided) set at P < 0.05. Arteriole dilator responses (response to acetylcholine or DETA-NONOate) were assessed by comparing post-treatment response with baseline control response using 2-way repeated measures analysis of variance (ANOVA) with pairwise posthoc analysis using Holm-Sidak method, while comparison between two treatment responses were analyzed using 2-way ANOVA with pairwise post-hoc analysis using Holm-Sidak method. Acetylcholine half-maximal effective concentration (EC50, estimated dose that produces dilation to 50% of maximum dilation) was derived using nonlinear regression with a variable slope (four parameters) and least squares ordinary fit (GraphPad Prism 5.0, GraphPad software, La Jolla, CA) similar to our previous methods 6, 10 and compared between baseline and treatment response using paired Student t-test. For endothelial cell experiments, each data point (N) is a replicate that represents a separate independent HUVEC batch. For non-normally distributed data, natural log (Ln) transformation was first performed and ANOVA performed using normally distributed Ln transformed data. For endothelial cell assays, group treatment analyses were assessed using one-way repeated-measures analysis of variance (ANOVA) with post-hoc testing using Holm-Sidak pairwise comparison for normally distributed data. For datasets with treatment sample sizes that are not equal and data that are not normally distributed, one way ANOVA on ranks was done and Dunn's post hoc pairwise comparison testing performed. Paired comparisons that are not normally distributed were analyzed using Wilcoxon signed rank test. Statistical analyses were performed using Sigmastat 3.5 (Systat, San Jose, CA).
Results
Monomeric medin tissue concentration was determined from the aortic tissue of 12 donor participants. The range was 0-75 lg/g wet tissue (29.1 ± 8.9 lg/g). Assuming an aortic tissue density of 1 g/ml, 23 this corresponds to 0-13.72 lM (mean 5.34, standard deviation 5.66, median 4.36, interquartile range 4.36-9.84 lM) ( Figure 1A and B) . This physiologic dose range was used for our arteriole and endothelial cell experiments. There was significant correlation between aortic tissue medin content and age (R = 0.592, P = 0.04). Subjects who were 55 years old or older had significantly higher aortic medin than those <55 years old. 
Adipose arterioles exposed for 1 h to medin 5 lM showed reduced ÁNO and increased superoxide and peroxynitrite ( Figure 2F-H) . Similar results were seen in HUVECs for ÁNO and superoxide, however, the difference in peroxynitrite production between control and medin-treated cells did not reach statistical significance following 1 h exposure, unlike results following 20-h exposure (see results below).
To assess the role of oxidative stress in causing endothelial dysfunction, adipose and leptomeningeal arterioles were co-treated with antioxidant PEG-SOD and medin. PEG-SOD restored arteriole dilator response to acetylcholine (Figure 3A-D) . PEG-SOD also restored ÁNO production and reduced superoxide production in endothelial cells treated with medin ( Figure 3E-F) .
To assess whether medin's effect on reducing endothelial cell ÁNO and increasing superoxide is related to eNOS uncoupling, we measured phosphorylated and total eNOS. Endothelial cells treated with medin for 1 h did not show any difference with control in phosphorylated eNOS (serine 177 and threonine 495), total eNOS and phosphorylated eNOS/total eNOS ratios (Supplementary material online, Figure S1A -H). Adipose arterioles exposed to 1 h of medin plus essential NO synthase co-factor BH4 restored dilator response to acetylcholine compared with exposure to medin alone (Supplementary material online, Figure S1I ). In addition, co-treatment for 1 h with medin and BH4 restored NO and reduced superoxide production in endothelial cells when compared to medin treatment alone (Supplementary material online, Figure S1J -K); no group differences were noted in peroxynitrite production following 1 h treatment (Supplementary material online, Figure S1L ).
In order to assess the role of RAGE in mediating the vascular effects of medin, adipose arterioles were exposed to medin co-treated with FPS-ZM1 (100 mM), a multimodal, high affinity and specific inhibitor of RAGE.
14 Arteriole dilator response was compared between arterioles treated with medin and with medin co-treated with RAGE inhibitor FPS-ZM1. FPS-ZM1 restored dilator response to acetylcholine signifying preservation of endothelial function in both adipose and leptomeningeal arterioles ( Figure 4A-D) . There was a trend toward restoration of NO production with FPS-ZM1 co-treatment ( Figure 4E ) that did not reach statistical significance on pre-specified pairwise post-hoc analysis following repeated measures one way analysis of variance. However, paired t-test analysis of arteriole NO production of medin vs. medin þ FPS-ZM1 treatment showed significant difference (relative to control: 0.56 ± 0.9 vs. 0.89 ± 0.19 respectively, N = 7, P = 0.04). Furthermore, HUVECs treated for 1 h with medin þ FPS-ZM1 showed significantly higher ÁNO compared with medin-treated alone (signal relative to vehicle-control: 1.0 ± 0, medin 5 lM: 0.63 ± 0.05, medin þ FPS-ZM1 100 lM: 0.94 ± 0.14, P < 0.05 medin vs. C, P < 0.05 medin vs. medin þ FPS-ZM1, n = 10), similar to results obtained with 20 h exposure (see results below). FPS-ZM1 co-treatment resulted in reduced superoxide and peroxynitrite production in adipose arterioles following 1-h exposure ( Figure 4F and G). FPS-ZM1 co-treatment or FPS-ZM1 alone did not change levels of phosphorylated eNOS (both serine 177 and threonine 495) or phosphorylated eNOS/total eNOS ratio (Supplementary material online, Figure S2A -H).
We also assessed the effects of medin on endothelial cell viability and oxidative stress following 20-h exposure. There was dose-dependent reduction in ÁNO and increase in peroxynitrite ( Figure 5A and C) ; medin also increased superoxide production and reduced cell viability ( Figure  5B and D) . Co-treatment of medin with peroxynitrite decomposition 
catalyst FeTMPyP (200 lM) restored endothelial cell viability ( Figure 5E ). Medin also caused reduced endothelial cell proliferation and reduction in endothelial cell migration speed ( Figure 5F and G) .
Medin exposure for 20 h also caused increased gene and protein expression of IL-6 and IL-8 in HUVECs (Figure 6A-D) . There was a dosedependent increase in endothelial cell phospho-NFjB following 5 h of exposure to medin ( Figure 6E and F) . Additional replicates were performed to confirm the effects of medin on gene expression of IL-6 and IL-8, and results were consistent in showing significant increase in IL-6 (relative to control: control 1 ± 0, medin 5 lM 22.8±4.7, N = 33, P < 0.001) and IL-8 (relative to control: control 1 ± 0, medin 5 lM Figure S3 ). Co-treatment of medin with FPS-ZM1 also restored 20 h endothelial cell ÁNO production and cell viability while reversing medin-induced Figure 2 Effects of medin on human arteriole vasoreactivity and oxidative and nitrative stress. (A-C) Shows dilator response to acetylcholine in human adipose arterioles exposed to increasing doses of medin for 1 h. There was dose-dependent reduction in dilator response to acetylcholine in medin-treated arterioles signifying endothelium-dependent vasodilation. (D) Shows dilator response to ÁNO donor DETA-NONOate in adipose arterioles exposed to medin 5 lM for 1 h. There was no significant change in dilator response suggesting medin does not impair endothelium-independent vasodilation. (E) Shows that similar to response in adipose arterioles, medin-treated leptomeningeal arterioles show endothelial dysfunction with impaired dilator response to acetylcholine. To assess the bases of observed endothelial function in human arterioles treated with medin, NO, superoxide, and peroxynitrite levels were measured in adipose arterioles (F-H) and endothelial cells (I-K) treated with medin for 1 h. In both adipose arterioles and endothelial cell cultures, there was reduction in NO and increase in superoxide production signifying medin-induced oxidative stress and reduced ÁNO bioavailability. 
increase in peroxynitrite production ( Figure 7A-C) . FPS-ZM1 co-treatment also prevented phosphorylation of NFjB by medin as well as the increase in gene and protein expression of IL-6 and IL-8 ( Figure 7D-I) .
Discussion
The study presents the following novel findings. First, medin induced human arteriole and endothelial cell dysfunction likely through increased oxidative and nitrative stress. Second, medin caused profound proinflammatory signaling effect on endothelial cells mediated through activation of NFjB. Third, these adverse effects appear to be mediated via RAGE. These findings demonstrate a new mechanism of injury on human microvessels induced by medin that could be relevant in aging-related vascular pathology.
Endothelial dysfunction induced by medin
Despite reports suggesting that medin is a ubiquitous human amyloidogenic protein, being present in almost 100% of Caucasian subjects studied over 50 years of age, 2, 24 little is known about medin's pathophysiologic effects. Consistent with previous reports demonstrating increased arterial medin content with advanced age, [1] [2] [3] [4] we also show significant positive correlation between age and medin content in aortic tissue, with significantly increased medin in subjects > _55 years old vs. younger. Because previously published reports 1-4 on medin content in human vessels plus our current study still represent <100 total subjects studied, it is imperative that the epidemiology of medin vascular deposition be studied in larger subsets of patients to confirm findings of high prevalence with aging in a large population. A, C were analyzed using 2-way repeated measures ANOVA; B, D were analyzed using 2-way ANOVA with post-hoc Holm-Sidak pairwise test; E, F were analyzed using one-way repeated ANOVA with post-hoc Holm-Sidak pairwise test; *P < 0.05, **P < 0.01, ***P < 0.01 (in B, D control vs. treated group, in E, F groups in bracket). Our results show that medin induces profound endothelial dysfunction in human peripheral adipose and central leptomeningeal arterioles while reducing endothelial cell viability, migration and proliferation. This is likely due to induction of oxidative and nitrative stress (increased superoxide and peroxynitrite) leading to decreased ÁNO bioavailability, because co-treatment with superoxide scavenger PEG-SOD restored endothelial function, reduced superoxide, and increased ÁNO production. One possible mechanism underlying medin's oxidative stress effects may be due to eNOS uncoupling since our data showed no change in phospho-eNOS/eNOS ratio with medin treatment (suggesting diversion of eNOS activity from NO to superoxide production) and restoration of endothelial function, NO production with reduced superoxide following co-treatment with BH4, a nitric oxide synthase co-factor that promotes eNOS coupling. Because endothelial dysfunction is an early and key abnormality that underlies aging-related arterial diseases including essential hypertension and atherosclerosis, 25 our observations suggest a potential novel mechanism of vascular injury. Our results show that medin does not affect arteriole dilator response to DETANONOate, an NO donor, suggesting that medin does not affect downstream signaling of NO through guanylate cyclase and cyclic guanosine monophosphate (cGMP) to produce vasodilation. Our results show reduced endothelial cell viability following exposure to medin in the setting of increased superoxide and peroxynitrite production. NO and superoxide react and form as primary intermediate Figure 4 Restoration of medin-induced endothelial dysfunction by RAGE inhibitor. Co-treatment with medin and RAGE inhibitor FPS-ZM1 (100 lM) in adipose (A) or leptomeningeal (C) arterioles did not result in impaired dilation to acetylcholine compared with control. The change in dilator response from baseline control was significantly different between vessels treated with medin vs. medin þ FPS-ZM1 (B, D) showing that FPS-ZM1 restored dilator response of arterioles exposed to medin. (E) Co-treatment with FPS-ZM1 showed a trend, but not a statistically significant difference in ÁNO production in adipose arterioles treated with medin by pairwise post-hoc analysis following one way repeat measures ANOVA. However, paired t-test of ÁNO production of medin vs. medin þ FPS-ZM1 treatment showed significant difference (P = 0.04). 
the potent oxidant peroxynitrite. 17 Peroxynitrite is a potent mediator of cellular damage in a wide range of conditions including cardiovascular disease. 26 Our results demonstrated that FeTMPyP, a peroxynitrite decomposition catalyst, restored endothelial cell viability in the setting of medin exposure, suggesting that medin's effect on cell viability is mediated via peroxynitrite. Using a high-affinity specific inhibitor, we demonstrated that the effects of medin are mediated via RAGE. Another amyloidogenic peptide, bamyloid, uses the same receptor to mediate perturbations in cerebral vessels, neurons and microglia in AD. 27 Indeed, we previously showed that similar to medin, Ab42 induces endothelial dysfunction in leptomeningeal and adipose arterioles through reduced ÁNO bioavailability and induction of oxidative and nitrative stress. 7, 11 Since both medin and Ab were shown to be present in cerebral vessels especially with advanced age, it is important in future studies to fully define contributing effects on vascular function and possible interactions by both amyloid proteins.
Medin and proinflammatory vascular signaling
Our findings show that medin also induces pro-inflammatory signaling in endothelial cells with increased gene and protein expression of IL-6 29 In addition, studies suggest that IL-8 may also promote angiogenesis. 30 A potential implication is that the presence of medin could possibly amplify pro-inflammatory and oxidative stress signaling induced by other risk factors. Medin's stimulatory effects on gene expression of IL-6 and IL-8 were not reversed by co-treatment with PEG-SOD or FeTMPyp at doses that reversed medin-induced reduction of endothelial cell viability, suggesting that medin's proinflammatory effect is independent of superoxide or peroxynitrite generation. Although peroxynitrite has been shown to activate NFjBdependent proinflammatory signaling in human polymorphonuclear cells 26, 31, 32 and monocytes, 33 other investigators showed the opposite effect in other types of cells, 26, 34 including endothelial cells, 35 suggesting that the relationship between peroxynitrite and NFjB signaling is complex and may be cell-type and condition dependent.
The effects on immune signaling with chronic exposure remains to be studied, but if the pro-inflammatory response seen with acute exposure is not muted, a state of prolonged vascular inflammation could be created with potential implications for long-term atherosclerosis development. There is no prior study that we know of that showed pro-inflammatory effects and reduced endothelial function following exposure to medin; however, our findings are complementary to the work by Peng et al. 3 showing that vascular smooth muscle cells exposed to medin increased Figure 7 RAGE inhibitor protects viability of endothelial cells and prevents pro-inflammatory signaling following medin treatment. In A-C, co-treatment for 20 h of RAGE inhibitor FPS-ZM1 (100 lM) with medin restored endothelial cell viability, restored NO production and reduced peroxynitrite production compared with medin treatment alone. D-E Shows that FPS-ZM1 co-treatment with medin also reduces phosphorylated NFjB levels, gene and protein expression of interleukin (IL)-6 and IL-8. Note that to facilitate data representation, logarithmic scale was used in F, H-I. A, C-D and F-I: N = 5 each, B: C-N = 22, medin-N = 22, medin þ FPS-ZM1-N = 5; A, C, D, F-I were analyzed using repeated measures ANOVA with post-hoc pairwise Holm-Sidak, B was analyzed using 1-way ANOVA with post-hoc pairwise Holm-Sidak; *P < 0.05, **P < 0.01, ***P < 0.001.
Endothelial dysfunction induced by medin the production of matrix metalloproteinase-2, a protease that degrades elastin and collagen leading to weakening of the vessel wall. The same group observed that medin was present in the temporal arteries of both elderly patients and patients with giant cell arteritis, 4 with the authors raising the question of the role of medin in arterial inflammation.
Potential homology with other amyloid proteins
Our results show very similar mechanisms of injury induced on human microvessels by medin when compared to our previous studies on amyloidogenic light chain proteins 6 and b-amyloid, 7,11 despite having widely varying amino acid sequences. The exact basis for this observation remains unknown but other studies suggest a structural homology shared by misfolded proteins. Kayed et al. 36 showed that six amyloid proteins with no sequence homology nevertheless showed similar cellular cytotoxicity, and administration of antibody against soluble oligomers culled from various amyloid proteins uniformly protected against cytotoxicity in all six amyloid species. Lashuel et al. 37 showed using electron microscopy that three amyloid proteins associated with Parkinson's disease and Alzheimer's disease with widely variant amino acid sequences showed similar annular morphologic tertiary structure conformations that are indistinguishable from each other, which they postulate may underlie the common toxicity among these amyloid proteins. Our group's current and prior findings that medin, amyloid light chains and bamyloid show similar effects of endothelial dysfunction, oxidative and nitrative stress are consistent with this body of work by other investigators. Another implication of this observation is that the multi-organ toxicity seen with many misfolded proteins may be mediated, at least in part, by common effects on the microcirculation and that therapeutic approaches to mitigate the deleterious effects on the microvasculature may have general, not just protein-or disease-specific, utility.
Human microvascular model
Our findings also demonstrate similarity in degree and direction of response to medin in peripheral subcutaneous adipose and central leptomeningeal arterioles. This is similar to our results when we exposed living subject adipose, cadaver adipose and leptomeningeal arterioles to Ab42 11 and when adipose arterioles and atrial coronary arterioles were exposed to AL light chain proteins. 6 This supports the contention that more easily obtainable subcutaneous adipose arterioles could be acceptable surrogates to study pathophysiologic responses in central (cerebrovascular or coronary) arterioles. This has potential translational relevance in offering a new ex vivo human model for studying vascular pathophysiology.
Limitations
This study has several important limitations. Our human ex vivo vascular model and endothelial cell experiments only studied acute, and not chronic, effects of medin exposure. It is not known whether chronic exposure will lead to sustained vascular insult and this needs to be established in future studies to better determine the link with human agingrelated vascular pathology. The study lacked in vivo confirmation and our results should be confirmed in vivo with future animal experiments. Despite this limitation, the results of our acute exposure experiments remain salient by providing important foundational knowledge on potential mechanisms of action underlying medin vascular effects that would be relevant starting points in studying in vivo pathophysiology and mechanisms. Although it is intuitive to attribute, at least in part, the reduction in endothelial cell proliferation following medin exposure to medin's effect in reducing cell viability based on prior work showing the tight relationship between endothelial cell viability and proliferation, 38 the study did not specifically explore this relationship. Future studies should look into whether medin's effect is also due to dysregulation of known signaling pathways regulating endothelial cell proliferation such as expression of growth factors (e.g. vascular endothelial growth factor) or MAPK signaling. 39 Our results support the possible role of eNOS uncoupling by medin in causing oxidative and nitrative stress, but future studies need to determine if other sources of oxidative stress such as mitochondria or nicotinamide adenine dinucleotide phosphate oxidase, among others, may be affected by medin since a previous study demonstrated multiple sources of superoxide production induced by another type of amyloidogenic protein (light chains in AL). 6 Although we measured only IL-6 and IL-8, in light of activation of NFjB, we anticipate, but did not verify, that other cytokines known to be upregulated by NFjB will also be increased by medin. We limited our study on RAGE and did not formally test whether other endothelial cell receptors known to mediate inflammation, such us toll-like receptors, are involved. The degree of medin's effect on inflammatory cytokine gene and protein expression in endothelial cells is substantial. Our results showed $27 times increase in IL-8 protein expression (control 1716 ± 398 vs. medin 5 lM 47046 ± 10836 pg/mL, P < 0.01, Figure 6D ). To put this in context, human umbilical veins exposed for 24 h to lipopolysaccharide (100 ng/ml), a classic proinflammatory bacterial agent, increased IL-8 only 4-6 times. 40 Our findings do not explain the discrepancy between the degrees of gene and protein expression increases in IL-8. To investigate this interesting observation, future follow-up studies should be performed to systematically investigate potential causes including mRNA stability, rate of mRNA decay and factors that may be affecting protein expression at the post-transcriptional level. The gender composition of our sources of adipose arterioles is not diversified despite our attempts to actively recruit both male and female participants owing to the current makeup of the elective surgical population in our Veteran's Affairs hospital. Although there is a potential link between medin effects and vascular dysfunction associated with aging, and our results show increased medin aortic content in subjects >55 years old vs. younger, we did not look at aging/senescence markers in our vessels or endothelial cells to further explore these relationships, an area of future study. Although the investigators were careful in using a consistent %weight/volume amount of tissue for loading aortic tissue for western blot, the lack of measurement of a control protein to correct for loading could potentially overestimate or underestimate actual medin tissue content.
Conclusions
In conclusion, physiologic doses of medin induces RAGE-mediated human peripheral and central arteriole endothelial dysfunction, with dysregulated endothelial cell NO bioavailability, oxidative and nitrative stress leading to reduced endothelial cell viability and proinflammatory signaling via NFjB activation (proposed schema in Figure 8 ). This advances our understanding of the acute effects of medin in vascular function and identifies a potential novel mechanism of vascular injury.
Supplementary material
Supplementary material is available at Cardiovascular Research online. Based on our findings, we propose that medin causes oxidative and nitrative stress in human microvessels leading to endothelial dysfunction and reduced endothelial cell viability and proliferation. Medin also causes pro-inflammatory signaling mediated via activation of NFjB. The effects of medin are mediated via receptor for advanced glycation endproducts.
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